— Know what they know.
Not Investment Advice
Also trades as: BOT.AX (ASX) · $vol 0M

BXPHF OTC

Botanix Pharmaceuticals Limited
1W: +46.8% 1M: -4.8% 3M: +40.4% YTD: -79.8% 1Y: -88.1% 3Y: -86.6% 5Y: -77.1%
$0.02
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 47 · $43.7M mcap · 1.88B float · 0.0019% daily turnover · Short 72% of daily vol

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Rating Summary
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2025-07-29 Williams Trading — Initiated $0 — +91.1% $0.14

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
Sep 30, 2026
DCF
3
ROE
1
ROA
1
D/E
3
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. BXPHF receives an overall rating of C+. Strongest factors: P/B (4/5). Areas of concern: ROE (1/5), ROA (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-09-30 None ADDED
2026-09-30 EXISTED None
2026-09-26 None ADDED
2026-09-26 EXISTED None
2026-09-21 C+ B-
2026-09-19 None ADDED
2026-09-19 EXISTED None
2026-09-15 None ADDED
2026-09-13 EXISTED None
2026-09-09 None ADDED

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade D
Profitability
0
Balance Sheet
39
Earnings Quality
42
Growth
52
Value
—
Momentum
50
Safety
—
Cash Flow
30

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
2/9
✗ ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✓
Beneish M-Score
5.07
Possible Manipulator
Ohlson O-Score
3.29
Bankruptcy prob: 96.4%
High Risk
Credit Rating
BB+
Score: 49.0/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.92x
Accruals: -11.9%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. BXPHF scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. BXPHF's score of 5.07 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. BXPHF's implied 96.4% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. BXPHF receives an estimated rating of BB+ (score: 49.0/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.56x
PEG
-0.02x
P/S
1.04x
P/B
0.68x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. BXPHF currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.026
EBT / EBIT
×
EBIT Margin
-3.779
EBIT / Rev
×
Asset Turnover
0.369
Rev / Assets
×
Equity Multiplier
1.268
Assets / Equity
=
ROE
-181.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. BXPHF's ROE of -181.3% is driven by Asset Turnover (0.369), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1685 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.02
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.01
Ann. Volatility
376.5%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
ROE -21.1% -70.8% -64.6% -96.5% -82.4% -1.0% -1.0% -1.0% -71.2% -39.4% -90.3% -1.9% -2.6% -1.8% -1.81%
ROA -19.7% -66.1% -60.1% -91.4% -74.1% -83.9% -91.6% -95.4% -65.5% -36.4% -82.0% -1.3% -1.8% -1.4% -1.43%
ROIC -1.8% 32.6% -4.1% 55.1% 9.3% -20.9% -2.8% -1.8% -83.8% -75.5% -89.4% -1.6% -1.9% -2.9% -2.85%
ROCE -10.4% -34.9% -32.0% -48.0% -68.1% -1.0% -65.0% -48.6% -29.3% -16.9% -51.7% -92.9% -1.8% -2.0% -2.03%
Gross Margin 99.4% -11.3% 98.8% 575.8% — 94.7% -2.2% -4.1% -8.0% -58.1% -2.2% 52.6% -1.7% -1.7% -1.70%
Operating Margin -3.8% -1499.7% -1.8% 42627.2% — -6.8% -21.3% -8.6% -17.2% -5.2% -82.1% -9.2% -2.0% -2.0% -1.98%
Net Margin -1.9% -1497.7% 19.3% 42533.3% — -4.8% -11.8% -8.6% -14.5% -5.0% -81.8% -10.3% -2.0% -2.0% -2.03%
EBITDA Margin -91.6% -736.5% 9.2% 21271.8% — -2.4% -5.9% -4.3% -7.3% -5.0% -81.7% -9.2% -2.0% -2.0% -1.98%
FCF Margin -3.9% -4.6% -3.2% -2.8% -3.0% -3.5% -12.8% -14.5% -17.7% -14.1% -20.8% -13.0% -4.8% -3.6% -3.56%
OCF Margin -3.9% -4.6% -3.1% -2.8% -3.0% -2.9% -8.2% -10.1% -8.4% -6.8% -15.1% -11.0% -4.8% -3.6% -3.55%
ROE 3Y Avg snapshot only -1.57%
ROA 3Y Avg snapshot only -95.18%
ROIC Economic snapshot only -1.53%
Cash ROA snapshot only -1.35%
Cash ROIC snapshot only -3.44%
CROIC snapshot only -3.45%
NOPAT Margin snapshot only -2.94%
Pretax Margin snapshot only -3.88%
R&D / Revenue snapshot only 0.36%
SGA / Revenue snapshot only 2.30%
SBC / Revenue snapshot only 50.95%
Valuation
Metric Trend Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
P/E Ratio — — — — — — — — — — — — — — -0.559
P/S Ratio — — — — — — — — — — — — — — 1.039
P/B Ratio — — — — — — — — — — — — — — 0.676
P/FCF — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — —
Leverage & Solvency
Metric Trend Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Current Ratio 17.18 17.98 15.64 20.82 5.92 1.78 3.08 7.42 9.50 22.21 10.63 4.00 2.56 2.59 2.591
Quick Ratio 17.18 17.98 15.64 20.82 5.92 1.27 2.31 5.75 8.14 21.89 7.95 2.87 1.56 1.58 1.579
Debt/Equity 0.01 0.02 0.01 0.01 0.01 0.02 0.00 0.01 0.00 0.00 0.01 0.39 0.56 0.23 0.232
Net Debt/Equity -0.81 -1.02 -0.76 -1.02 -1.16 -0.88 -0.52 -0.44 -0.40 -0.73 -0.51 -0.40 -0.03 -0.34 -0.345
Debt/Assets 0.01 0.02 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.25 0.30 0.14 0.139
Debt/EBITDA -0.13 -0.05 -0.04 -0.03 -0.02 -0.01 -0.00 -0.01 -0.00 -0.00 -0.02 -0.35 -0.25 -0.10 -0.099
Net Debt/EBITDA 7.71 2.94 2.38 2.14 1.72 0.87 0.80 0.91 1.72 5.05 1.07 0.36 0.01 0.15 0.147
Interest Coverage -203.14 -163.64 -97.99 -93.83 -89.45 -109.11 -89.63 -109.68 -150.36 -191.05 -2434.20 -20.80 -20.00 -20.36 -20.362
Equity Multiplier 1.07 1.07 1.08 1.06 1.20 1.72 1.24 1.08 1.05 1.03 1.08 1.59 1.83 1.67 1.668
Cash Ratio snapshot only 1.182
Debt Service Coverage snapshot only -19.900
Cash to Debt snapshot only 2.485
FCF to Debt snapshot only -9.742
Defensive Interval snapshot only 170.2 days
Efficiency & Turnover
Metric Trend Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Asset Turnover 0.11 0.15 0.27 0.33 0.13 0.25 0.07 0.10 0.08 0.05 0.05 0.10 0.33 0.37 0.369
Inventory Turnover — — — — — 0.16 0.94 2.61 4.75 4.72 0.99 0.63 3.38 6.01 6.005
Receivables Turnover — 28.99 — 159.31 — 35.52 23.90 10.36 24.32 10.01 6.28 4.84 8.10 11.36 11.364
Payables Turnover 0.02 0.10 0.11 0.30 0.22 0.08 0.73 4.02 6.07 2.71 2.93 1.92 12.49 22.76 22.755
DSO 0 13 0 2 0 10 15 35 15 36 58 75 45 32 32.1 days
DIO 0 0 0 0 0 2337 389 140 77 77 368 579 108 61 60.8 days
DPO 17499 3604 3350 1211 1653 4369 500 91 60 135 124 190 29 16 16.0 days
Cash Conversion Cycle -17499 -3591 -3350 -1209 -1653 -2022 -96 84 32 -21 302 464 124 77 76.9 days
Fixed Asset Turnover snapshot only 49.384
Operating Cycle snapshot only 92.9 days
Cash Velocity snapshot only 1.101
Capital Intensity snapshot only 2.628
Growth (YoY)
Metric Trend Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Revenue — — — — -8.7% 27.3% -75.6% -68.3% -22.6% -38.1% 68.5% 2.4% 8.0% 12.5% 12.49%
Net Income — — — — -1.8% 1.4% -35.5% -11.3% -8.7% -39.5% -1.3% -3.5% -5.0% -5.8% -5.78%
EPS — — — — -1.6% 1.4% -29.1% 17.5% 26.5% 13.2% -27.4% -2.1% -3.4% -3.4% -3.44%
FCF — — — — 29.3% 2.1% 1.2% -62.7% -3.5% -1.5% -1.7% -2.1% -1.5% -2.4% -2.41%
EBITDA — — — — -1.8% 0.6% -36.4% -11.4% -10.1% -91.6% -3.1% -7.3% -10.4% -8.5% -8.46%
Op. Income — — — — -82.9% -8.0% 7.5% 16.8% -8.2% -7.3% -80.1% -2.3% -3.3% -4.3% -4.34%
OCF Growth snapshot only -6.08%
Asset Growth snapshot only -5.90%
Equity Growth snapshot only -41.66%
Shares Change snapshot only 52.53%
Growth (CAGR)
Metric Trend Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Revenue 3Y — — — — — — — — — — — — 85.1% 1.2% 1.20%
Revenue 5Y — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — — — — — 40.5% 61.1% 61.10%
Assets 5Y — — — — — — — — — — — — — — —
Equity 3Y — — — — — — — — — — — — 17.7% 39.0% 38.97%
Book Value 3Y — — — — — — — — — — — — -9.0% 3.0% 3.04%
Dividend 3Y — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Revenue Stability — — — — — — — — 0.95 0.19 0.55 0.01 0.56 0.58 0.582
Earnings Stability — — — — — — — — 0.84 0.72 0.87 0.77 0.70 0.64 0.636
Margin Stability — — — — — — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.500
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.97 0.84 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — 0.32 1.15 0.44 -0.26 -1.46 -1.34 -1.343
Gross Margin Trend — — — — — — — — -2.75 -3.33 -2.94 -0.34 -0.73 -0.72 -0.718
FCF Margin Trend — — — — — — — — -14.20 -10.03 -12.85 -4.30 5.49 5.26 5.265
Sustainable Growth Rate — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
OCF/Net Income 2.09 1.04 1.41 1.01 0.53 0.86 0.67 1.04 1.05 0.88 0.91 0.86 0.90 0.92 0.917
FCF/OCF 1.01 1.01 1.00 1.00 1.00 1.21 1.55 1.43 2.11 2.08 1.37 1.17 1.00 1.00 1.002
FCF/Net Income snapshot only 0.919
CapEx/Revenue 2.1% 2.4% 1.3% 1.4% 0.7% 60.8% 4.6% 4.4% 9.3% 7.3% 5.7% 1.9% 1.5% 0.7% 0.71%
CapEx/Depreciation snapshot only 0.083
Accruals Ratio 0.21 0.02 0.25 0.01 -0.35 -0.12 -0.31 0.04 0.03 -0.04 -0.07 -0.18 -0.17 -0.12 -0.119
Sloan Accruals snapshot only -0.306
Cash Flow Adequacy snapshot only -499.683
Dividends & Buybacks
Metric Trend Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Dividend Yield — — — — — — — — — — — — — — 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Tax Burden (NI/EBT) 0.48 0.69 0.53 0.58 0.74 0.63 0.77 0.78 0.77 0.86 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 4.19 2.91 3.80 3.44 2.69 3.16 2.59 2.58 2.09 1.45 1.03 1.04 1.02 1.03 1.026
EBIT Margin -0.92 -2.20 -1.11 -1.39 -2.85 -1.72 -6.18 -4.87 -4.98 -6.17 -16.17 -12.31 -5.21 -3.78 -3.779
Asset Turnover 0.11 0.15 0.27 0.33 0.13 0.25 0.07 0.10 0.08 0.05 0.05 0.10 0.33 0.37 0.369
Equity Multiplier 1.07 1.07 1.08 1.06 1.11 1.24 1.14 1.07 1.09 1.08 1.10 1.48 1.47 1.27 1.268
Per Share
Metric Trend Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
EPS (Diluted TTM) $-0.01 $-0.02 $-0.02 $-0.02 $-0.02 $-0.02 $-0.02 $-0.02 $-0.01 $-0.01 $-0.03 $-0.05 $-0.07 $-0.07 $-0.07
Book Value/Share $0.04 $0.02 $0.03 $0.02 $0.01 $0.01 $0.02 $0.02 $0.03 $0.07 $0.05 $0.04 $0.03 $0.03 $0.03
Tangible Book/Share $0.04 $0.02 $0.03 $0.02 $0.01 $0.00 $0.01 $0.01 $0.02 $0.05 $0.03 $0.03 $0.01 $0.02 $0.02
Revenue/Share $0.00 $0.00 $0.01 $0.01 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.01 $0.02 $0.01
FCF/Share $-0.02 $-0.02 $-0.02 $-0.02 $-0.01 $-0.02 $-0.02 $-0.03 $-0.03 $-0.03 $-0.03 $-0.05 $-0.06 $-0.06 $-0.03
OCF/Share $-0.02 $-0.02 $-0.02 $-0.02 $-0.01 $-0.01 $-0.01 $-0.02 $-0.02 $-0.01 $-0.02 $-0.05 $-0.06 $-0.06 $-0.03
Cash/Share $0.03 $0.03 $0.02 $0.02 $0.02 $0.01 $0.01 $0.01 $0.01 $0.05 $0.03 $0.03 $0.02 $0.02 $0.02
EBITDA/Share $-0.00 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01 $-0.02 $-0.05 $-0.06 $-0.06 $-0.06
Debt/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.02 $0.02 $0.01 $0.01
Net Debt/Share $-0.03 $-0.02 $-0.02 $-0.02 $-0.02 $-0.01 $-0.01 $-0.01 $-0.01 $-0.05 $-0.03 $-0.02 $-0.00 $-0.01 $-0.01
Academic Models
Metric Trend Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Altman Z-Score — — — — — — — — — — — — — — —
Piotroski F-Score 1 1 1 1 3 4 2 1 3 4 4 3 3 2 2
Beneish M-Score — — — — — 204.17 68.65 — — -0.10 -0.44 0.12 36.63 5.07 5.065
Ohlson O-Score snapshot only 3.285
ROIC (Greenblatt) snapshot only -3.04%
Net-Net WC snapshot only $0.02
EVA snapshot only $-122690443.41
Credit
Metric Trend Q2'20 Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Q4'26 Current
Credit Rating snapshot only BB+
Credit Score 51.00 51.00 51.00 51.00 51.00 46.80 51.00 51.00 55.00 55.00 51.00 50.00 47.45 48.95 48.950
Credit Grade snapshot only 11
Credit Trend snapshot only -6.050
Implied Spread (bps) snapshot only 400.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms